title: Cardiovascular side effects of aminophylline in meconium-induced acute lung injury.
abstract: As inflammation plays an important role in the pathogenesis of neonatal meconium aspiration syndrome (MAS), anti-inflammatory agents including inhibitors of phosphodiesterases (PDE) are increasingly used in the treatment. To evaluate side effects of PDE inhibitors, this study analyzed changes in blood pressure, heart rate (HR) and heart rate variability (HRV) during and after intravenous aminophylline in the animal model of MAS. Oxygen-ventilated rabbits were given meconium intratracheally (25 mg/ml, 4 ml/kg) or saline. Thirty minutes later, the animals were treated by intravenous aminophylline (Syntophyllin, 2 mg/kg) or saline (sham-treated controls). A second dose of the treatment was given 2 h later. During (5 min) and immediately after (5 min) the treatment, and during 5 h after the treatment, mean blood pressure in the femoral artery (MAP), HR and HRV were evaluated. In meconium-instilled animals, increases in MABP, HR, and HRV were observed already 5 min after aminophylline administration, while in saline-instilled animals aminophylline increased HR and caused inconsistant changes in HRV parameters compared to sham-treated animals. Within 5 h after the treatment administration, MAP, HR, and HRV parameters gradually returned to the initial values. Concluding, intravenous aminophylline may lead to acute cardiovascular changes. Thus, if aminophylline is used for treatment of MAS, its possible cardiovascular effects should be considered, particularly in patients with cardiovascular instability.
authors: Department of Physiology, Comenius University, Slovakia. mokra@jfmed.uniba.sk
authors: D
authors: D
authors: Mokra
authors: I
authors: I
authors: Tonhajzerova
authors: J
authors: J
authors: Mokry
authors: M
authors: M
authors: Petraskova
authors: M
authors: M
authors: Hutko
authors: A
authors: A
authors: Calkovska
mesh_terms: D000628:Aminophylline / Q000627:therapeutic use / Q000633:toxicity*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity*; D002319:Cardiovascular System / Q000187:drug effects*; D004195:Disease Models, Animal; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects; D008470:Meconium; D008471:Meconium Aspiration Syndrome / Q000188:drug therapy*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits
chemical_list: D001993:Bronchodilator Agents; D010726:Phosphodiesterase Inhibitors; D000628:Aminophylline